# Simon Fiduciaria

> Simon Fiduciaria is a VC fund in Turin backing Software, Health Care and Artificial Intelligence. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Turin, Italy
- Total investments: 11
- Last investment: Feb 2026
- Lead investor: 9%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/simon-fiduciaria/
- Website: https://www.simonfiduciaria.it

Simon Fiduciaria is a VC fund in Turin focused on Software and Health Care. Simon Fiduciaria offers fiduciary services.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.1M–$7.6M |
| Pre-Seed | $614k–$1.6M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 3 | 27% |
| Health Care | 3 | 27% |
| Artificial Intelligence | 3 | 27% |
| Therapeutics | 2 | 18% |
| Manufacturing | 2 | 18% |

28 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 55% |
| Pre-Seed | 2 | 18% |
| Series A | 1 | 9% |
| Series B | 1 | 9% |
| Funding Round | 1 | 9% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Italy | 8 | 73% |
| India | 1 | 9% |
| Switzerland | 1 | 9% |
| United Kingdom | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AutoConnexa | Connexa InsTech is a digital and telematics insurance company solution offering unprecedented customer-centricity and flexibility. It was founded in 2021 and its headquarters is located in Bari, Apulia, Italy. | $5.2M | Seed | Feb 24, 2026 |  |
| Displaid | Displaid develops monitoring and management of bridges and viaducts for infrastructure network, IoT sensors, and AI algorithms. | $1.4M | Seed | Jul 16, 2025 |  |
| MgShell | MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures. | $1.3M | Seed | Apr 30, 2025 |  |
| Annaida Technologies | Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies. |  | Seed | Apr 29, 2025 |  |
| Soource | Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide. | $1.6M | Pre-Seed | Jan 21, 2025 |  |
| Yoyomove | Yoyomove is a long-term car rental company that offers long-term vehicle rental and flexible mobility solutions designed to simplify your everyday journeys | $1.1M | Seed | Oct 17, 2024 |  |
| AIKO - Infinite Ways to Autonomy | Aiko develops and commercializes algorithms based on Artificial Intelligence to increase the autonomy of satellite missions. | $4.4M | Series A | Oct 09, 2024 |  |
| Inventio.AI | Inventio.AI is a software development company that provides artificial intelligence tools and solutions for machines and productions. | $614.1K | Pre-Seed | Oct 01, 2024 |  |
| Even | Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost. | $20.1M | Venture - Series Unknown | Aug 21, 2024 |  |
| NeoPhore | NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.The company's small molecule therapies target genetic mechanisms in order to create neoantigen which is known to stimulate the immune system and potentially be a weak spot in a tumor cell's defense mechanisms,enabling cancer patients to get treated and achieve improved clinical outcomes. | $12.2M | Series B | Feb 01, 2024 |  |

10 of 11 investments shown.

## Co-investors
- [Club degli Investitori](https://shizune.co/investors/profile/club-degli-investitori) — VC Fund, 4 deals together
- [360 Capital](https://shizune.co/investors/profile/360-capital-partners) — VC Fund, 3 deals together
- [Claris Ventures](https://shizune.co/investors/profile/claris-ventures) — VC Fund, 3 deals together
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund, 2 deals together
- [LIFTT](https://shizune.co/investors/profile/liftt) — VC Fund, 2 deals together
- [2invest](https://shizune.co/investors/profile/2invest-f4d3) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [MS&AD Ventures](https://shizune.co/investors/profile/ms-ad-ventures) — VC Fund
- [Anthemis](https://shizune.co/investors/profile/anthemis-group) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund
- [Club degli Investitori](https://shizune.co/investors/profile/club-degli-investitori) — VC Fund
- [Primo Capital](https://shizune.co/investors/profile/barcamper-ventures) — VC Fund

## Featured in investor lists
- [Artificial intelligence VC Funds in Italy](https://shizune.co/investors/artificial-intelligence-vc-funds-italy)
- [Climate VC Funds in Italy](https://shizune.co/investors/climate-vc-funds-italy)
- [Health Care VC Funds in Italy](https://shizune.co/investors/health-care-vc-funds-italy)
- [Transportation Investors in Italy](https://shizune.co/investors/transportation-investors-italy)
- [Medical Device VC Funds in Italy](https://shizune.co/investors/medical-device-vc-funds-italy)
- [Life Science Investors in Switzerland](https://shizune.co/investors/life-science-investors-switzerland)

## FAQ

### What does Simon Fiduciaria invest in?

Simon Fiduciaria invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 11 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Simon Fiduciaria's check size?

Simon Fiduciaria typically joins rounds of $1.1M–$7.6M at Seed and $614k–$1.6M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Simon Fiduciaria participates in.

### When did Simon Fiduciaria last invest?

The most recent investment recorded for Simon Fiduciaria closed in Feb 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co